Prothena Corp PLC (PRTA) Stock Price, Quote, News & History

PRTANASDAQ
$8.49
N/A
At close: Aug 4, 5:00 PM EST
$8.45
-0.04-0.47%
Pre-Market: 8:03 AM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-81.34M
Investing Cash Flow (TTM)
-96.00K
Financing Cash Flow (TTM)
-7.04M
Free Cash Flow (TTM)
-81.44M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-88.47M

Analyst Trends and Forecast

0
0
0
0
Feb
0
0
0
0
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.6
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$122.67M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
7.90
PB Ratio (TTM)
1.42
Earnings Yield % (TTM)
-33.10%
Earnings Yield % (FWD)
-1.83%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$5.97

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$329.46M
Debt to Equity
0.02
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$8.49
Volume / Avg.
1.23K / 576.25K
Day Range
- - -
52 Wk Range
6.73 - 11.80
Market Cap
$442.38M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
43
Short Interest
18.78%
Days to Cover
16.4

About

Sector
Health Care
Industry
Biotechnology
Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amy...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Prothena Corp (PRTA) stock?

A

You can purchase shares of Prothena Corp (NASDAQ:PRTA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Prothena Corp (PRTA) competitors?

A

There are no as such competitors for Prothena Corp.

Q

What is the forecast, or price target, for Prothena Corp (PRTA) stock?

A

Prothena Corp has a consensus price target of $27.82.

Q

What is the current price for Prothena Corp (PRTA)?

A

The stock price for Prothena Corp (NASDAQ: PRTA) is $8.45 last updated August 6, 2026 at 4:53 AM EDT.

Q

Does Prothena Corp (PRTA) pay a dividend?

A

There are no upcoming dividends for Prothena Corp.

Q

When is Prothena Corp (NASDAQ:PRTA) reporting earnings?

A

Prothena Corp does not have any upcoming earnings scheduled.

Q

Is Prothena Corp (PRTA) going to split?

A

There is no upcoming split for Prothena Corp.

Q

What sector and industry does Prothena Corp (PRTA) operate in?

A

Prothena Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.